185 related articles for article (PubMed ID: 47148)
21. In vivo activation of properdin factor B in normotensive bacteremic individuals.
Palestine AG; Klemperer MR
J Immunol; 1976 Aug; 117(2):703-5. PubMed ID: 950469
[No Abstract] [Full Text] [Related]
22. Serum complement levels in bacteremia due to gram-negative organisms.
McCabe WR
N Engl J Med; 1973 Jan; 288(1):21-3. PubMed ID: 4629164
[No Abstract] [Full Text] [Related]
23. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
Vogt W; Schmidt G; Lynen R; Dieminger L
J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
[TBL] [Abstract][Full Text] [Related]
24. Immunofluorescence studies on complement components in the hair follicles of normal scalp and of scalp affected by alopecia areata.
Igarashi R; Morohashi M; Takeuchi S; Sato Y
Acta Derm Venereol; 1981; 61(2):131-5. PubMed ID: 6165188
[TBL] [Abstract][Full Text] [Related]
25. Influence of age and sex on serum complement components in children.
Roach B; Kim Y; Jerome E; Michael AF
Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
[TBL] [Abstract][Full Text] [Related]
26. Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.
Ruddy S; Austen KF; Goetzl EJ
J Clin Invest; 1975 Mar; 55(3):587-92. PubMed ID: 1167871
[TBL] [Abstract][Full Text] [Related]
27. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.
Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG
Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133
[TBL] [Abstract][Full Text] [Related]
28. The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative Pathway.
Michels MAHM; Maas RJF; van der Velden TJAM; van de Kar NCAJ; van den Heuvel LPWJ; Volokhina EB;
J Immunol; 2021 Nov; 207(10):2465-2472. PubMed ID: 34635587
[TBL] [Abstract][Full Text] [Related]
29. New procedure for the detection of complement deficiency by ELISA. Analysis of activation pathways and circumvention of rheumatoid factor influence.
Fredrikson GN; Truedsson L; Sjöholm AG
J Immunol Methods; 1993 Dec; 166(2):263-70. PubMed ID: 8288879
[TBL] [Abstract][Full Text] [Related]
30. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils.
Wirthmueller U; Dewald B; Thelen M; Schäfer MK; Stover C; Whaley K; North J; Eggleton P; Reid KB; Schwaeble WJ
J Immunol; 1997 May; 158(9):4444-51. PubMed ID: 9127010
[TBL] [Abstract][Full Text] [Related]
31. Complement alterations in inflammatory bowel disease.
Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
[TBL] [Abstract][Full Text] [Related]
32. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
33. Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.
Takahashi M; Takahashi S; Brade V; Nussenzweig V
J Clin Invest; 1978 Aug; 62(2):349-58. PubMed ID: 670397
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
35. Serum complement levels before and after the onset of acute post-streptococcal glomerulonephritis. A case report.
Strife CF; Forristal TJ; Forristal J
Pediatr Nephrol; 1994 Apr; 8(2):214-5. PubMed ID: 8018502
[TBL] [Abstract][Full Text] [Related]
36. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
[TBL] [Abstract][Full Text] [Related]
37. Serum complement levels in infancy: age related changes.
Davis CA; Vallota EH; Forristal J
Pediatr Res; 1979 Sep; 13(9):1043-6. PubMed ID: 503656
[TBL] [Abstract][Full Text] [Related]
38. Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria.
Eichenberger EM; Dagher M; Ruffin F; Park L; Hersh L; Sivapalasingam S; Fowler VG; Prasad BC
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2121-2131. PubMed ID: 32621149
[TBL] [Abstract][Full Text] [Related]
39. Changes in humoral components of host defense following burn trauma.
Bjornson AB; Altemeier WA; Bjornson HS
Ann Surg; 1977 Jul; 186(1):88-96. PubMed ID: 879873
[TBL] [Abstract][Full Text] [Related]
40. Properdin homeostasis requires turnover of the alternative complement pathway.
Wu X; Xu TQ; Atkinson JP
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19444-8. PubMed ID: 20974943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
